{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:20:27Z","timestamp":1770909627169,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jacep.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T09:16:24Z","timestamp":1509959784000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Impact of Atrial Fibrillation Clinical\u00a0Subtype on Mortality"],"prefix":"10.1016","volume":"4","author":[{"given":"Melissa","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe J.","family":"van Rosendael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachid","family":"Abou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Ajmone Marsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2017.09.002_bib1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2017.09.002_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A\u00a0population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jacep.2017.09.002_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/jama.1981.03310400022019","article-title":"Mortality in an insured population with atrial fibrillation","volume":"245","author":"Gajewski","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2017.09.002_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1445-5994.1989.tb00271.x","article-title":"Atrial fibrillation and mortality in an elderly population","volume":"19","author":"Lake","year":"1989","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.jacep.2017.09.002_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a062312","article-title":"Chronic atrial fibrillation\u2014epidemiologic features and 14 year follow-up: a case control study","volume":"8","author":"Onundarson","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2017.09.002_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(87)90174-7","article-title":"Risk of stroke in non-rheumatic atrial fibrillation","volume":"1","author":"Flegel","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2017.09.002_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiologic features of chronic atrial fibrillation: the Framingham study","volume":"306","author":"Kannel","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2017.09.002_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/hrt.39.8.889","article-title":"Longitudinal survey of ischaemic heart disease in randomly selected sample of older population","volume":"39","author":"Kitchin","year":"1977","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacep.2017.09.002_bib12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib13","doi-asserted-by":"crossref","first-page":"e002597","DOI":"10.1161\/CIRCHEARTFAILURE.115.002597","article-title":"Beta-blockers in atrial fibrillation patients with or without heart failure: association with mortality in a nationwide cohort study","volume":"9","author":"Nielsen","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacep.2017.09.002_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2014.09.031","article-title":"Statin treatment is associated with improved prognosis in patients with AF-related stroke","volume":"177","author":"Ntaios","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib15","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2215\/CJN.03170509","article-title":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease","volume":"5","author":"Ananthapanyasut","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacep.2017.09.002_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000443314","article-title":"Presence of atrial fibrillation at the time of dialysis initiation is associated with mortality and cardiovascular events","volume":"132","author":"Tanaka","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.jacep.2017.09.002_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacep.2017.09.002_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2017.09.002_bib21","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2017.09.002_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest J"},{"key":"10.1016\/j.jacep.2017.09.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacep.2017.09.002_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to\u00a0reduced versus preserved ejection fraction: a\u00a0systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2005.07.050","article-title":"Effect of atrial fibrillation pattern on survival in a community-based cohort","volume":"96","author":"Keating","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2017.09.002_bib27","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and\u00a0stroke risk the trends study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2017.09.002_bib30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2017.09.002_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/anec.12345","article-title":"Type of atrial fibrillation and clinical outcomes in patients undergoing transcatheter aortic valve replacement","volume":"21","author":"Shaul","year":"2016","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/heartjnl-2015-308678","article-title":"All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome","volume":"201","author":"Batra","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2017.09.002_bib33","first-page":"1004","article-title":"CHA2DS2-VAS(C) and CHADS2 scores predict adverse clinical events in patients with pacemakers and sinus node dysfunction independent of atrial fibrillation","volume":"31","author":"Glotzer","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacep.2017.09.002_bib34","first-page":"129","article-title":"Persistent atrial fibrillation from the onset: a\u00a0specific subgroup of patients with biatrial substrate involvement and poorer clinical outcome","volume":"2","author":"Lim","year":"2016","journal-title":"J\u00a0Am Coll Cardiol EP"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X17307235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X17307235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:24:26Z","timestamp":1762500266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X17307235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2405500X17307235"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2017.09.002","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Atrial Fibrillation Clinical\u00a0Subtype on Mortality","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}